首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1569472

肺炎检测市场规模、份额和成长分析：按产品类型、类型、最终用户、地区划分 - 产业预测，2024-2031 年

Pneumonia Testing Market Size, Share, Growth Analysis, By Product Type, By Type, By End-user, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月13日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年肺炎检测的全球市场规模为5.25亿美元，从2023年的5.5965亿美元增至2031年的9.332亿美元，并且在预测期内（2024-2031年）将以复合年增长率增长。。

肺炎检测市场受到各种动态驱动和阻碍因素因素的影响，形成其成长轨迹。肺炎发病率不断上升，特别是在老龄化人口和慢性疾病患者中，加上空气污染水平不断上升，大大推动了对有效诊断解决方案的需求。同时，人们对早期诊断和治疗的必要性的认识不断提高，尤其是儿童和老年人等高风险族群，这进一步推动了市场的发展。诊断技术的进步，包括分子诊断和就地检验，对于提高检测的准确性和可近性至关重要，特别是在服务不足的社区。然而，挑战仍然存在，例如经济限制限制了某些地区获得先进诊断的机会，严格的监管核准可能会抑制产品创新和市场进入。儘管存在这些障碍，但对预防性医疗保健的更多关注以及提高负担能力和准确性的持续研究预计将在可预见的未来维持市场势头。同样，由于对气候变迁的担忧以及对清洁能源来源的需求，生质能发电产业正在经历显着成长。有机生物质提供了一种永续的能源解决方案，可促进能源安全，同时减少对进口的依赖。支持可再生能源措施的政府政策也正在推动全球生物质计划的投资。然而，市场面临来自其他产业对生物质原料的竞争、潜在的负面环境影响、物流障碍以及能源转换过程的技术限制等挑战。应对这些挑战对于释放生物质在全球能源格局中的全部潜力至关重要。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Quidel Corporation（US）
Becton, Dickinson, and Company（US）
Meridian Bioscience, Inc.（US）
Qiagen NV（Netherlands）
bioMerieux SA（France）
Bio-Rad Laboratories Inc.（US）
Cardinal Health Inc.（US）
Hologic Inc.（US）
La Roche Ltd.（Switzerland）
Abbott Laboratories（US）
Quest Diagnostics（US）
Luminex Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Agena Bioscience, Inc.（US）
Roche Diagnostics（Switzerland）
Grifols, SA（Spain）
PerkinElmer, Inc.（US）
Genoa Healthcare, LLC（US）
SeraCare Life Sciences, Inc.（US）
Randox Laboratories Ltd.（UK）
Acon Laboratories, Inc.（US）

简介目录

Product Code: SQMIG35D2250

Global Pneumonia Testing Market size was valued at USD 525 million in 2022 and is poised to grow from USD 559.65 million in 2023 to USD 933.2 million by 2031, growing at a CAGR of 6.60% during the forecast period (2024-2031).

The pneumonia testing market is influenced by various dynamic drivers and constraints that shape its growth trajectory. Increasing pneumonia prevalence, particularly among aging populations and those with chronic diseases, alongside rising air pollution levels, significantly propels demand for effective diagnostic solutions. Alongside this, heightened awareness of the need for early diagnosis and treatment in at-risk groups, particularly children and the elderly, further drives the market. Technological advancements in diagnostic methods-including molecular diagnostics and point-of-care testing-are crucial in enhancing testing accuracy and accessibility, particularly in underserved areas. However, challenges such as economic limitations in certain regions restrict access to advanced diagnostics, while stringent regulatory approvals can impede product innovation and market entry. Despite these hurdles, a growing focus on preventive healthcare and ongoing research to improve affordability and accuracy is expected to sustain market momentum in the foreseeable future. Similarly, the biomass power generation sector is experiencing significant growth, fueled by the need for cleaner energy sources amid climate change concerns. Biomass, sourced from organic materials, presents a sustainable energy solution that promotes energy security while reducing reliance on imports. Government policies supporting renewable energy initiatives also bolster investment in biomass projects globally. Nevertheless, the market faces challenges, including competition for biomass feedstock with other industries, the potential for negative environmental impacts, logistical hurdles, and technological limitations in energy conversion processes. Addressing these challenges will be crucial for unlocking the full potential of biomass in the global energy landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pneumonia testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global pneumonia testing Market Segmental Analysis

Global Pneumonia Testing Market is segmented by Product Type, Type, End-user, and region. Based on Product Type, the market is segmented into Instruments, Reagents & Consumables. Based on Type, the market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others. Based on End-user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global pneumonia testing Market

Demographic trends represent a significant market driver for the global pneumonia testing market, as aging populations worldwide are witnessing a rise in the incidence of pneumonia. With increased life expectancy, many elderly individuals face health challenges, including compromised immune systems that heighten their vulnerability to respiratory infections like pneumonia. This demographic shift not only amplifies the need for accurate and timely testing but also drives the demand for innovative diagnostic solutions tailored to this age group. Consequently, healthcare providers are increasingly focusing on enhancing pneumonia diagnostic capabilities, establishing a robust market for pneumonia testing technologies and services.

Restraints in the global pneumonia testing Market

One of the key market restraints for the global pneumonia testing market is the economic constraints experienced by healthcare systems, particularly in low- and middle-income regions. Limited healthcare budgets often hinder the ability of institutions to invest in advanced diagnostic technologies, which are essential for effective pneumonia testing. Disparities in healthcare access further exacerbate the issue, as marginalized communities may lack the necessary facilities and resources to implement comprehensive testing programs. These economic challenges lead to a slower adoption of pneumonia testing solutions, ultimately stalling market growth and limiting the availability of early diagnosis and treatment for this serious illness.

Market Trends of the global pneumonia testing Market

The global pneumonia testing market is experiencing a significant shift towards point-of-care testing, largely fueled by the demand for rapid diagnostics in emergency and primary care environments. With an increasing emphasis on early disease detection and prompt treatment initiation, point-of-care tests provide healthcare professionals with the capability to deliver immediate results, enhancing clinical decision-making and ultimately improving patient outcomes. This trend is further supported by technological advancements in diagnostic tools and an expanding focus on personalized healthcare solutions, thereby reshaping the landscape of pneumonia management and positioning point-of-care testing as a pivotal component of contemporary healthcare strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition
PESTEL Analysis

Pneumonia Testing Market by Product Type

Market Overview
Instruments
Reagents & Consumables

Pneumonia Testing Market by Type

Market Overview
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others

Pneumonia Testing Market by End-user

Market Overview
Hospitals & Clinics
Diagnostic Centers
Others

Pneumonia Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agena Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoa Healthcare, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

02-2729-4219

+886-2-2729-4219

License/价格

肺炎检测市场规模、份额和成长分析：按产品类型、类型、最终用户、地区划分 - 产业预测，2024-2031 年

Pneumonia Testing Market Size, Share, Growth Analysis, By Product Type, By Type, By End-user, By Region - Industry Forecast 2024-2031

目录

介绍

调查方法

执行摘要

市场动态及展望

主要市场考察

肺炎检测市场：依产品类型

肺炎检测市场：按类型

肺炎检测市场：依最终用户分类

肺炎检测市场规模：按地区划分

竞争格局